(Q61920871)
Statements
A Phase IV, Open-Label, Multi-Centre Trial Evaluating the Conversion From Standard Phosphate Binder Therapy to Fosrenol® in Chronic Kidney Disease Stage 5 Patients on Haemodialysis (English)
0 references
May 2007
0 references
68
0 references
18 year
0 references